Complete financial analysis of Indiva Limited (NDVAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Indiva Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Daeduck Co.,Ltd. (00806K.KS) Income Statement Analysis – Financial Results
- Dowa Holdings Co., Ltd. (5714.T) Income Statement Analysis – Financial Results
- Summus Solutions N.V. (WENEF) Income Statement Analysis – Financial Results
- Commercial Vehicle Group, Inc. (CVGI) Income Statement Analysis – Financial Results
- Sichuan Zigong Conveying Machine Group Co., Ltd. (001288.SZ) Income Statement Analysis – Financial Results
Indiva Limited (NDVAF)
About Indiva Limited
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA and Artisan Batch brands, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 37.57M | 34.40M | 32.47M | 14.65M | 923.86K | 58.31K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 23.35K | 29.13K | 17.41K | 38.32K | 69.96K | 121.59K | 65.59K |
| Cost of Revenue | 27.05M | 26.25M | 25.40M | 15.52M | 869.50K | 43.14K | 188.37K | 1.16K | 4.01K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.82K | 17.96K | 6.29K | 25.29K | 52.57K | 70.58K | 48.65K |
| Gross Profit | 10.52M | 8.15M | 7.07M | -873.55K | 54.36K | 15.16K | -188.37K | -1.16K | -4.01K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.53K | 11.17K | 11.12K | 13.03K | 17.39K | 51.01K | 16.94K |
| Gross Profit Ratio | 28.00% | 23.70% | 21.76% | -5.96% | 5.88% | 26.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 32.26% | 38.35% | 63.89% | 34.01% | 24.86% | 41.95% | 25.82% |
| Research & Development | 877.01K | 1.02M | 416.96K | 11.64K | 122.59K | 24.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.01M | 6.29M | 6.56M | 5.86M | 6.92M | 6.74M | 2.06M | 889.99K | 219.93K | 918.44K | 83.36K | 81.67K | 110.20K | 205.35K | 116.63K | 178.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 5.35M | 6.53M | 4.94M | 1.61M | 2.16M | 605.46K | 364.92K | 222.57K | 34.97K | 57.25K | 0.00 | 1.02K | 848.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 11.37M | 12.82M | 11.50M | 7.47M | 9.08M | 7.35M | 2.42M | 1.11M | 254.90K | 975.69K | 83.36K | 82.69K | 111.04K | 205.35K | 116.63K | 178.84K | 379.13K | 356.69K | 168.15K | 334.90K | 165.46K | 167.19K | 178.89K |
| Other Expenses | 402.92K | 413.50K | 1.59M | 3.18M | 953.44K | 0.00 | -2.33K | -8.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.42K | 0.00 | -846.56K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 12.65M | 14.25M | 13.51M | 10.66M | 10.15M | 7.75M | 2.76M | 1.14M | 258.91K | 976.59K | 83.36K | 82.69K | 111.04K | 205.35K | 116.76K | 179.08K | 386.42K | 361.96K | 175.49K | 345.38K | 176.72K | 172.80K | 180.65K |
| Cost & Expenses | 39.70M | 40.50M | 38.91M | 26.18M | 11.02M | 7.71M | 2.76M | 1.14M | 258.91K | 976.59K | 83.36K | 82.69K | 111.04K | 205.35K | 116.76K | 179.08K | 402.24K | 379.92K | 181.78K | 370.67K | 229.29K | 243.38K | 229.30K |
| Interest Income | 0.00 | 36.13K | 217.69K | 7.00 | 137.33K | 112.88K | 29.65K | 0.00 | 0.00 | 1.57K | 0.00 | 0.00 | 1.27K | 44.00 | 92.00 | 5.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 4.91M | 4.45M | 2.93M | 2.02M | 439.54K | 1.16M | 248.65K | 0.00 | 0.00 | 14.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 45.24K | 0.00 | 26.55K | 28.22K | 64.34K | 42.95K | 677.00 | 5.86K |
| Depreciation & Amortization | 393.33K | 410.48K | 484.93K | 386.93K | 862.85K | 407.09K | 188.37K | 29.84K | 4.01K | 906.00 | -166.72K | -165.37K | -222.09K | -378.92K | 126.00 | 240.00 | 7.29K | 5.27K | 7.34K | 10.49K | 11.27K | 5.61K | 1.76K |
| EBITDA | 272.34K | -5.89M | -11.04M | -11.03M | -10.10M | -7.13M | -948.25K | -1.10M | -235.46K | -974.12K | -83.36K | -82.69K | -111.04K | 1.03M | 453.30K | 1.78M | -371.60K | -345.52K | -157.03K | -321.87K | -148.07K | -116.19K | -161.95K |
| EBITDA Ratio | 0.72% | -17.13% | -34.00% | -75.27% | -1,027.15% | -12,230.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1,591.41% | -1,186.15% | -902.10% | -840.03% | -211.65% | -95.56% | -246.91% |
| Operating Income | -2.13M | -6.10M | -6.44M | -8.74M | -10.10M | -7.54M | -1.14M | -1.13M | 258.91K | 971.22K | 83.36K | 82.69K | 111.04K | 1.41M | 686.69K | 2.18M | -378.89K | 350.79K | 164.37K | 332.35K | 159.33K | 121.80K | 163.71K |
| Operating Income Ratio | -5.66% | -17.73% | -19.84% | -59.68% | -1,092.91% | -12,928.20% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1,622.64% | 1,204.26% | 944.28% | 867.40% | 227.75% | 100.18% | 249.59% |
| Total Other Income/Expenses | -2.79M | -4.95M | -9.94M | -6.54M | -1.30M | -1.01M | -475.68K | -59.36K | -11.49K | -2.12M | -166.72K | -165.37K | -220.82K | -1.23M | -569.93K | -2.81M | 0.00 | -350.79K | -164.37K | -332.35K | -159.33K | -121.80K | -163.71K |
| Income Before Tax | -4.92M | -11.05M | -15.28M | -15.42M | -11.40M | -8.66M | -4.60M | -1.17M | -767.60K | -1.15M | -83.36K | -82.69K | -109.78K | 178.00K | 116.76K | -622.24K | 0.00 | 0.00 | 0.00 | 0.00 | 191.35K | 147.83K | 0.00 |
| Income Before Tax Ratio | -13.09% | -32.12% | -47.05% | -105.26% | -1,233.72% | -14,845.72% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 273.51% | 121.58% | 0.00% |
| Income Tax Expense | 0.00 | -118.30K | -266.95K | 1.06K | 46.87K | -129.46K | -47.96K | 20.93K | 508.69K | 14.00K | 0.00 | 0.00 | 220.82K | 1.61M | 570.29K | 2.02M | 40.15K | 26.55K | 28.22K | 64.34K | 42.95K | 677.00 | 5.86K |
| Net Income | -4.92M | -10.93M | -15.01M | -15.42M | -11.44M | -8.53M | -4.55M | -1.17M | -767.60K | -1.15M | -83.36K | -82.69K | -109.78K | -1.43M | -687.05K | -3.04M | -419.03K | -377.34K | -192.59K | -396.70K | -170.27K | -96.45K | -169.57K |
| Net Income Ratio | -13.09% | -31.78% | -46.22% | -105.27% | -1,238.80% | -14,623.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1,794.57% | -1,295.41% | -1,106.39% | -1,035.33% | -243.37% | -79.33% | -258.53% |
| EPS | -0.03 | -0.08 | -0.11 | -0.16 | -0.14 | -0.11 | -0.12 | -0.05 | -2.72 | -4.97 | -0.86 | -1.13 | -1.58 | -37.85 | -30.97 | -155.52 | -22.88 | -34.33 | -20.84 | -60.99 | -26.18 | -14.83 | -26.07 |
| EPS Diluted | -0.03 | -0.08 | -0.11 | -0.16 | -0.14 | -0.11 | -0.12 | -0.05 | -2.72 | -4.97 | -0.86 | -1.13 | -1.58 | -37.85 | -30.97 | -155.52 | -22.88 | -34.33 | -20.84 | -60.99 | -26.18 | -14.83 | -26.07 |
| Weighted Avg Shares Out | 168.92M | 134.91M | 134.48M | 95.62M | 83.16M | 79.55M | 37.28M | 21.44M | 282.30K | 230.90K | 97.45K | 72.94K | 69.34K | 37.86K | 22.19K | 19.58K | 18.31K | 10.99K | 9.24K | 6.50K | 6.50K | 6.50K | 6.50K |
| Weighted Avg Shares Out (Dil) | 168.92M | 134.91M | 134.48M | 95.62M | 83.16M | 79.55M | 38.44M | 21.44M | 282.30K | 230.90K | 97.45K | 72.94K | 69.34K | 37.86K | 22.19K | 19.58K | 18.31K | 10.99K | 9.24K | 6.50K | 6.50K | 6.50K | 6.50K |
Indiva May be Delayed in Filing Annual Audited Financial Statements
LONDON, Ontario, April 23, 2021 (GLOBE NEWSWIRE) -- Indiva Limited ("Indiva" or the "Company") (TSX-V: NDVA) (OTCQX: NDVAF) announced today that it may be delayed in filing its annual audited financial statements for the year ended December 31, 2020 and...
Indiva Reports Record Market Share for February 2021
LONDON, Ontario, March 11, 2021 (GLOBE NEWSWIRE) -- Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), the leading Canadian producer of cannabis edibles, is pleased to announce record market share for the month of February. Indiva's edible products continue to...
Indiva Engages Independent Trading Group as Market-Maker and Investor Relations and Marketing Firm
LONDON, Ontario, March 05, 2021 (GLOBE NEWSWIRE) -- Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), the leading Canadian producer of cannabis edibles and other cannabis products, today announced that it has engaged the services of Independent Trading Group Inc....
Indiva Announces Appointment of New Director and Option Grant
LONDON, March 01, 2021 (GLOBE NEWSWIRE) -- Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce that Mr. Russell Wilson has been appointed to the board...
Sundial and Indiva Announce Closing of $22 Million Strategic Investment
Brokered Private Placement Offering of $11,000,000 and $11,000,000 Term Loan Facility Brokered Private Placement Offering of $11,000,000 and $11,000,000 Term Loan Facility
Indiva Announces Extension to License Agreement With Award-Winning Wana Brands Inc.
LONDON, Ontario, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), the leading Canadian producer of cannabis edibles, is pleased to announce an amendment and extension to its license agreement with Wana Brands (“Wana”) Inc.
Sundial and Indiva Announce $22 Million Strategic Investment
Brokered Private Placement Offering of $11,000,000 in Common Shares Plus $11,000,000 Term Loan Facility Brokered Private Placement Offering of $11,000,000 in Common Shares Plus $11,000,000 Term Loan Facility
Indiva Provides Guidance of Record Net Revenue for Fiscal Q4 2020
Indiva Continues to Lead the Edibles Market Nationally Indiva Continues to Lead the Edibles Market Nationally
Source: https://incomestatements.info
Category: Stock Reports